Di Zhao

University Of Tx Md Anderson Can Ctr

$3,648,377

Attributed

$3,648,377

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY2018–25

$2M$1.5M$1M$500K$0

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$3,648,377 · 4

By mechanism

R01$2,810,191 · 2

R00$745,906 · 1

K99$92,280 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Tx Md Anderson Can Ctr

Same institution · by research overlap

Cassian Yee$17,221,393
Min Sup Song$4,833,294
Ahmed Kaseb$3,699,074
Hesham M Amin$3,011,396
Timothy Anthony Yap$1,826,936

Others in their field

Other Emerging Leaders on “Malignant Neoplasms”

Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
Martha Hering · Westat, Inc.$57,098,843

Research focus

Malignant NeoplasmsCancer CellGenetically Engineered MouseTranscriptomicsResistanceCombination ImmunotherapyTargeted TreatmentMouse ModelRb1 GeneAdvanced Prostate CancerProstate Cancer ProgressionMalignant Neoplasm Of ProstateAntitumor EffectPten GeneTp53 GenePathway InteractionsTumorIn VivoAndrogen Deprivation TherapyMutationPhenotypeInfiltrationTumor MicroenvironmentImmunotherapy